| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 21 |
| 1 | METFORMIN ER 500 MG | 21 |
| 2 | METFORMIN ER 750 MG | 21 |
| 3 | PANCRELIPASE | 18 |
| 4 | TEDUGLUTIDE | 18 |
| 5 | TIRZEPATIDE | 18 |
| 6 | ADALIMUMAB | 17 |
| 7 | OMEPRAZOLE MAGNESIUM | 17 |
| 8 | OMEPRAZOLE | 14 |
| 9 | GABAPENTIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 1 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 2 | SETMELANOTIDE | 1 | 0.0035 |
| 3 | NAFTIFINE HYDROCHLORIDE | 1 | 0.0030 |
| 4 | I. V. FAT EMULSION | 2 | 0.0028 |
| 5 | TEDUGLUTIDE | 18 | 0.0013 |
| 6 | COLESTIPOL HYDROCHLORIDE | 3 | 0.0011 |
| 7 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 8 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 9 | 0.0011 |
| 9 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 37 |
| 1 | Benzodiazepine [EPC] | 25 |
| 2 | Provitamin D2 Compound [EPC] | 24 |
| 3 | Corticosteroid [EPC] | 21 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 5 | GLP-2 Analog [EPC] | 18 |
| 6 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 18 |
| 7 | Proton Pump Inhibitor [EPC] | 16 |
| 8 | Atypical Antipsychotic [EPC] | 14 |
| 9 | Expectorant [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | GLP-2 Analog [EPC] | 18 | 0.0013 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 4 | Human C1 Esterase Inhibitor [EPC] | 3 | 0.0008 |
| 5 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 6 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 7 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 8 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |